Xi'an Jiaotong University

The PhD in Pharmacology at Xi'an Jiaotong University (XJTU) is a comprehensive and prestigious three-year program tailored specifically for international students who aspire to gain deep expertise in pharmacology and the pharmaceutical sciences. This program is fully conducted in English, providing an ideal platform for students from diverse backgrounds to engage with complex topics and advanced research in this vital field. Throughout this rigorous doctoral program, students will explore essential pharmacological principles that include drug development, mechanisms of drug action, and therapeutic applications. The curriculum is designed to emphasize scientific rigor and research proficiency, featuring a balanced blend of theoretical coursework and practical laboratory experience. Students will participate in cutting-edge research while working alongside esteemed faculty members who are recognized leaders in pharmacological science, thus gaining invaluable insights and mentorship that will significantly enhance their academic journey. XJTU boasts modern laboratories and state-of-the-art research facilities, offering students the necessary resources to conduct significant studies in pharmacology. Additionally, students will have opportunities to collaborate on interdisciplinary projects, contributing to groundbreaking discoveries that have the potential to improve health outcomes worldwide. Living in the rich cultural environment of Xi'an, an ancient city steeped in history, further enhances the student experience by providing a unique blend of scholarly engagement and cultural interaction. The total tuition fee for this three-year program is 150,000 CNY, with an annual fee of 50,000 CNY. Prospective applicants should take note of the application deadline of June 30, 2026, to begin their studies in September 2026. Graduates from this program will emerge as knowledgeable leaders in pharmacology, well-equipped to contribute to research, academia, and the pharmaceutical industry, thereby making a meaningful impact on healthcare.